Labetalol hydrochloride 200 MG Oral Tablet — RxCUI 896762
RxNorm drug concept · Semantic clinical drug
RxCUI 896762
Semantic clinical drug · SCD
● Current RxNorm concept 87 FDA products
176 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI896762
Official nameLabetalol hydrochloride 200 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aslabetalol HCl 200 MG Oral Tablet
FDA products mapped87
Package NDCs mapped176
Reported Medicaid activity (SDUD)508,168 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Labetalol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Labetalol lowers blood pressure. The tablets are used for high blood pressure, and the IV form is used in the hospital for severe high blood pressure. Keeping blood pressure down r...
- Take them by mouth, usually twice a day, as your prescriber directs. Food increases how much of the drug your body absorbs, so try to be consistent about taking it with or without...
- Dizziness, nausea, tiredness and headache are the most common, and they often fade early in treatment. Standing up slowly helps with lightheadedness. Call your doctor if you get it...
- Please don't stop suddenly. Stopping a beta blocker abruptly can worsen chest pain and, in some cases, lead to a heart attack. If you need to stop, your prescriber will lower the d...
🕸️ Concept Web — How Labetalol hydrochloride 200 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Labetalol hydrochloride 200 MG Oral Tablet
RxCUI 896762 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Labetalol
6185IN -
Labetalol hydrochloride
202693PIN
-
Labetalol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Trandate
152440BN
-
Trandate
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Labetalol Oral Tablet
372554SCDF -
Labetalol hydrochloride Oral Tablet
2647737SCDFP -
Labetalol Oral Product
1161586SCDG -
Labetalol Pill
1161587SCDG -
Labetalol hydrochloride Oral Product
2659265SCDGP -
Labetalol hydrochloride Pill
2662343SCDGP -
Labetalol Oral Tablet [Trandate]
368577SBDF -
Labetalol hydrochloride Oral Tablet [Trandate]
2654334SBDFP - +5 more in this family
-
Labetalol Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Labetalol hydrochloride 200 MG
896761SCDC -
Labetalol hydrochloride 200 MG Oral Tablet [Trandate]
896781SBD -
Labetalol hydrochloride 200 MG [Trandate]
896780SBDC
-
Labetalol hydrochloride 200 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Labetalol hydrochloride 200 MG
SCDC · 896761 -
Labetalol Oral Tablet
SCDF · 372554 -
Labetalol hydrochloride Oral Tablet
SCDFP · 2647737 -
Labetalol Oral Product
SCDG · 1161586 -
Labetalol Pill
SCDG · 1161587 -
Labetalol hydrochloride Oral Product
SCDGP · 2659265 -
Labetalol hydrochloride Pill
SCDGP · 2662343
Brand-Name Concepts
-
Labetalol hydrochloride 200 MG Oral Tablet [Trandate]
SBD · 896781 -
Labetalol hydrochloride 200 MG [Trandate]
SBDC · 896780 -
Labetalol Oral Tablet [Trandate]
SBDF · 368577 -
Labetalol hydrochloride Oral Tablet [Trandate]
SBDFP · 2654334 -
Trandate Oral Product
SBDG · 1179177 -
Trandate Pill
SBDG · 1179178 -
Trandate
BN · 152440
📦 FDA Products & Package NDCs
87 products · 176 package NDCs
176 package NDCs map to RxCUI 896762 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00591-0605-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0605-01) | Labetalol hydrochloride | Actavis Pharma, Inc. | 1998-08-03 |
| 00591-0605-05 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0591-0605-05) | Labetalol hydrochloride | Actavis Pharma, Inc. | 1998-08-03 |
| 00615-8512-39 | 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8512-39) | Labetalol Hydrochloride | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-06-14 |
| 00615-8513-39 | 30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8513-39) | Labetalol Hydrochloride | NCS HealthCare of KY, LLC dba Vangard Labs | 2024-06-18 |
| 00904-7451-61 | 100 BLISTER PACK in 1 CARTON (0904-7451-61) / 1 TABLET, FIL... | Labetalol Hydrochloride | Major Pharmaceuticals | 2024-10-08 |
| 00904-7452-61 | 100 BLISTER PACK in 1 CARTON (0904-7452-61) / 1 TABLET, FIL... | Labetalol Hydrochloride | Major Pharmaceuticals | 2024-10-08 |
| 00904-7453-61 | 100 BLISTER PACK in 1 CARTON (0904-7453-61) / 1 TABLET, FIL... | Labetalol Hydrochloride | Major Pharmaceuticals | 2024-10-08 |
| 10135-0711-01 | 100 TABLET, FILM COATED in 1 BOTTLE (10135-711-01) | Labetalol Hydrochloride | Marlex Pharmaceuticals Inc | 2020-10-01 |
| 10135-0711-05 | 500 TABLET, FILM COATED in 1 BOTTLE (10135-711-05) | Labetalol Hydrochloride | Marlex Pharmaceuticals Inc | 2020-10-01 |
| 10135-0712-01 | 100 TABLET, FILM COATED in 1 BOTTLE (10135-712-01) | Labetalol Hydrochloride | Marlex Pharmaceuticals Inc | 2020-10-01 |
| 10135-0712-05 | 500 TABLET, FILM COATED in 1 BOTTLE (10135-712-05) | Labetalol Hydrochloride | Marlex Pharmaceuticals Inc | 2020-10-01 |
| 10135-0713-01 | 100 TABLET, FILM COATED in 1 BOTTLE (10135-713-01) | Labetalol Hydrochloride | Marlex Pharmaceuticals Inc | 2020-10-01 |
| 10135-0713-05 | 500 TABLET, FILM COATED in 1 BOTTLE (10135-713-05) | Labetalol Hydrochloride | Marlex Pharmaceuticals Inc | 2020-10-01 |
| 23155-0723-01 | 100 TABLET in 1 BOTTLE (23155-723-01) | Labetalol Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2020-02-22 |
| 23155-0723-05 | 500 TABLET in 1 BOTTLE (23155-723-05) | Labetalol Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2020-02-22 |
| 23155-0724-01 | 100 TABLET in 1 BOTTLE (23155-724-01) | Labetalol Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2020-02-22 |
| 23155-0724-05 | 500 TABLET in 1 BOTTLE (23155-724-05) | Labetalol Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2020-02-22 |
| 23155-0725-01 | 100 TABLET in 1 BOTTLE (23155-725-01) | Labetalol Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2020-02-22 |
| 23155-0725-05 | 500 TABLET in 1 BOTTLE (23155-725-05) | Labetalol Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2020-02-22 |
| 23155-0726-01 | 100 TABLET in 1 BOTTLE (23155-726-01) | Labetalol Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2026-05-15 |
| 23155-0726-05 | 500 TABLET in 1 BOTTLE (23155-726-05) | Labetalol Hydrochloride | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2026-05-15 |
| 29300-0252-01 | 100 TABLET, FILM COATED in 1 BOTTLE (29300-252-01) | Labetalol Hydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2022-10-01 |
| 29300-0252-05 | 500 TABLET, FILM COATED in 1 BOTTLE (29300-252-05) | Labetalol Hydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2022-10-01 |
| 29300-0253-01 | 100 TABLET, FILM COATED in 1 BOTTLE (29300-253-01) | Labetalol Hydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2022-10-01 |
| 29300-0253-05 | 500 TABLET, FILM COATED in 1 BOTTLE (29300-253-05) | Labetalol Hydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2022-10-01 |
| 29300-0254-01 | 100 TABLET, FILM COATED in 1 BOTTLE (29300-254-01) | Labetalol Hydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2022-10-01 |
| 29300-0254-05 | 500 TABLET, FILM COATED in 1 BOTTLE (29300-254-05) | Labetalol Hydrochloride | Unichem Pharmaceuticals (USA), Inc. | 2022-10-01 |
| 33342-0515-11 | 100 TABLET, FILM COATED in 1 BOTTLE (33342-515-11) | Labetalol Hydrochloride | Macleods Pharmaceuticals Limited | 2025-09-23 |
| 33342-0515-15 | 500 TABLET, FILM COATED in 1 BOTTLE (33342-515-15) | Labetalol Hydrochloride | Macleods Pharmaceuticals Limited | 2025-09-23 |
| 33342-0516-11 | 100 TABLET, FILM COATED in 1 BOTTLE (33342-516-11) | Labetalol Hydrochloride | Macleods Pharmaceuticals Limited | 2025-09-23 |
| 33342-0516-15 | 500 TABLET, FILM COATED in 1 BOTTLE (33342-516-15) | Labetalol Hydrochloride | Macleods Pharmaceuticals Limited | 2025-09-23 |
| 33342-0517-11 | 100 TABLET, FILM COATED in 1 BOTTLE (33342-517-11) | Labetalol Hydrochloride | Macleods Pharmaceuticals Limited | 2025-09-23 |
| 33342-0517-15 | 500 TABLET, FILM COATED in 1 BOTTLE (33342-517-15) | Labetalol Hydrochloride | Macleods Pharmaceuticals Limited | 2025-09-23 |
| 42806-0327-01 | 100 TABLET in 1 BOTTLE (42806-327-01) | Labetalol Hydrochloride | Epic Pharma, LLC | 2021-09-30 |
| 42806-0327-05 | 500 TABLET in 1 BOTTLE (42806-327-05) | Labetalol Hydrochloride | Epic Pharma, LLC | 2021-09-30 |
| 42806-0327-10 | 1000 TABLET in 1 BOTTLE (42806-327-10) | Labetalol Hydrochloride | Epic Pharma, LLC | 2021-09-30 |
| 42806-0328-01 | 100 TABLET in 1 BOTTLE (42806-328-01) | Labetalol Hydrochloride | Epic Pharma, LLC | 2021-09-30 |
| 42806-0328-05 | 500 TABLET in 1 BOTTLE (42806-328-05) | Labetalol Hydrochloride | Epic Pharma, LLC | 2021-09-30 |
| 42806-0328-10 | 1000 TABLET in 1 BOTTLE (42806-328-10) | Labetalol Hydrochloride | Epic Pharma, LLC | 2021-09-30 |
| 42806-0329-01 | 100 TABLET in 1 BOTTLE (42806-329-01) | Labetalol Hydrochloride | Epic Pharma, LLC | 2021-09-30 |
| 42806-0329-05 | 500 TABLET in 1 BOTTLE (42806-329-05) | Labetalol Hydrochloride | Epic Pharma, LLC | 2021-09-30 |
| 42806-0329-10 | 1000 TABLET in 1 BOTTLE (42806-329-10) | Labetalol Hydrochloride | Epic Pharma, LLC | 2021-09-30 |
| 50090-1290-00 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-1290-0) | Labetalol HCL | A-S Medication Solutions | 2014-11-28 |
| 50090-1290-01 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50090-1290-1) | Labetalol HCL | A-S Medication Solutions | 2015-08-06 |
| 50090-6774-00 | 100 TABLET, FILM COATED in 1 BOTTLE (50090-6774-0) | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | 2023-10-24 |
| 50090-6774-01 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-6774-1) | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | 2023-10-24 |
| 50090-6778-00 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-6778-0) | Labetalol hydrochloride | A-S Medication Solutions | 2023-10-25 |
| 50090-7523-00 | 100 TABLET, FILM COATED in 1 BOTTLE (50090-7523-0) | Labetalol Hydrochloride | A-S Medication Solutions | 2025-03-18 |
| 50090-7523-01 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-7523-1) | Labetalol Hydrochloride | A-S Medication Solutions | 2025-03-18 |
| 50090-7524-00 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-7524-0) | Labetalol Hydrochloride | A-S Medication Solutions | 2025-03-18 |
Observed labelers:
Bryant Ranch Prepack (18) ·
Biocon Pharma Inc. (12) ·
Cadila Pharmaceuticals Limited (12) ·
Zydus Lifesciences Limited (12) ·
Zydus Pharmaceuticals USA Inc. (12) ·
A-S Medication Solutions (9)
· +20 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.